You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – Interpace Diagnostics said today that it has signed a contract with Blue Shield of California to cover its ThyGeNext and ThyraMir thyroid cancer detection assays as an in-network service, which will limit members' out-of-pocket expenses.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.